相关实验视频
Updated: Jan 12, 2026

04:45
Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
Published on: June 2, 2022
2.7K
MD2通过TLR4/MyD88通路诱导呼吸道炎症和铁亡来调解COPD的发病过程
Xinru Xi1, Huiwen Chen2, Haoyu Ji2
1Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325600, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Biochimica et biophysica acta. Molecular basis of disease
|November 2, 2025
概括
骨髓分化蛋白2 (MD2) 通过促进呼吸道上皮细胞铁和炎症,加剧慢性阻塞性肺病 (COPD). 抑制MD2可能为COPD提供新的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球主要的死亡原因,其特点是空气流量限制和慢性炎症.
- 骨髓分化蛋白2 (MD2) 涉及肺部疾病的发病,但其在COPD进展中的具体作用尚不清楚.
研究的目的:
- 调查MD2在COPD和急性恶化病原发生中的功能作用.
- 探索MD2影响COPD呼吸道炎症和铁亡的潜在分子机制.
主要方法:
- 使用MD2淘汰赛小鼠和药物抑制剂 (L6H21) 来研究香烟烟雾引起的COPD和急性恶化 (AECOPD).
- 使用暴露于香烟烟雾提取物 (CSE) 的人类支气管上皮细胞 (BEAS-2B) 建立了体外模型.
- 使用分子生物学技术分析了MD2/TLR4/MyD88复合体形成,炎症标志物和铁亡指标.
主要成果:
- 在COPD患者和小鼠模型中,MD2表达升高.
- 在COPD和AECOPD模型中,MD2淘汰或抑制降低了呼吸道炎症和肺性铁亡.
- 在体外,MD2沉默或L6H21减轻了CSE诱导的NF-κB激活,促炎性基因表达和铁亡标志物.
结论:
- MD2通过TLR4/MyD88复合体促进呼吸道上皮细胞中的铁亡,并激活NF-κB介导的炎症,从而促进COPD的发病.
- MD2代表了COPD干预的潜在治疗目标.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K

